MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

27 Jul 2022 Evaluate
The sales surged to Rs. 449.44 millions, up 38.55% for the June 2022 quarter as against Rs. 324.40 millions during the corresponding quarter previous year.An average growth of 37.51% was recorded for the quarter ended June 2022 to Rs. 177.71  millions from Rs. 129.23 millions.OP of the company witnessed a marginal growth to 242.02 millions from 178.57 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 449.44 324.40 38.55 449.44 324.40 38.55 1148.54 905.63 26.82
Other Income 14.23 11.33 25.60 14.23 11.33 25.60 40.50 32.67 23.97
PBIDT 242.02 178.57 35.53 242.02 178.57 35.53 620.95 435.95 42.44
Interest 0.62 1.96 -68.37 0.62 1.96 -68.37 8.28 9.81 -15.60
PBDT 241.40 176.61 36.69 241.40 176.61 36.69 612.67 426.14 43.77
Depreciation 5.70 5.41 5.36 5.70 5.41 5.36 22.33 17.32 28.93
PBT 235.70 171.20 37.68 235.70 171.20 37.68 590.34 408.82 44.40
TAX 57.99 41.97 38.17 57.99 41.97 38.17 154.10 107.02 43.99
Deferred Tax -1.92 -0.42 357.14 -1.92 -0.42 357.14 0.72 1.26 -42.86
PAT 177.71 129.23 37.51 177.71 129.23 37.51 436.24 301.80 44.55
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 53.85 55.05 -2.17 53.85 55.05 -2.17 54.06 48.14 12.31
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..